2022 Revenues ($USD) : $1,695,571,096
2022 Revenues (foreign currencies) : SEK kr14,548,000,000
2022 R&D spend : $159,906,760
2022 Number of Employees : 4,631
Fiscal Year End : 4/30/2022
Company CEO : Gustaf Salford, president and CEO

The Swedish company has been a pioneer in precision radiation medicine since its founding in 1972. The company has offices in 120 countries and a listing on Nasdaq Stockholm. In 2022, Elekta launched its Elekta Esprit radiosurgery system and signed a global commercial collaboration agreement with GE Healthcare to expand precision radiation therapy access. –CN and JH